AbbVie Reports First-Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
AbbVie (ABBV) Tops Q1 EPS by 1c; Updates FY16 EPS Outlook
April 28, 2016 7:23 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $1.15, $0.01 better than the analyst estimate of $1.14. Revenue for the quarter came in at $5.96 billion versus the consensus estimate of $6.03 billion.
GUIDANCE:
AbbVie sees FY2016 EPS of $4.62-$4.82, versus the consensus of $4.97.
The company's 2016 adjusted... More
